CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 21 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $571,000 | – | 46,796 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,857,667 | $14,403,000 | 10.76% |
| Clarus Ventures, LLC | 2,752,488 | $13,873,000 | 10.42% |
| Rhenman & Partners Asset Management AB | 345,100 | $1,739,000 | 0.34% |
| Camber Capital Management LP | 1,000,000 | $5,040,000 | 0.30% |
| SPHERA FUNDS MANAGEMENT LTD. | 230,041 | $1,159,000 | 0.25% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 643,580 | $3,244,000 | 0.14% |
| Alambic Investment Management, L.P. | 12,673 | $64,000 | 0.02% |
| Spark Investment Management LLC | 12,200 | $61,000 | 0.01% |
| FRED ALGER MANAGEMENT, LLC | 114,782 | $579,000 | 0.00% |
| FEDERATED HERMES, INC. | 120,000 | $605,000 | 0.00% |